Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.01.2024 | Case report

Colistin/Gentamicin/Meropenem

Acquired drug resistance and drug intolerance

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bonilla-Moreno M, et al. Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient. Antimicrobial Agents and Chemotherapy 67: No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1128/aac.00272-23 Bonilla-Moreno M, et al. Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient. Antimicrobial Agents and Chemotherapy 67: No. 11, Nov 2023. Available from: URL: https://​dx.​doi.​org/​10.​1128/​aac.​00272-23
Metadaten
Titel
Colistin/Gentamicin/Meropenem
Acquired drug resistance and drug intolerance
Publikationsdatum
01.01.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52590-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Trastuzumab

Case report

Nivolumab

Case report

Cisplatin

Case report

Mutliple drugs